REFERENCES
- Kent JR, Almond MK. A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): Support for the ISPD guidelines. International Society for Peritoneal Dialysis. Perit Dial Int. 2000;20:301–305.
- Hurst SM, Wilkinson TS, McLoughlin RM, IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14:705–714.
- Enriquez J, Klinger J, Arturo JA, Delgado M, Tobar C, Mosquera M. Peritonitis in continuous ambulatory peritoneal dialysis: Cytokines in peritoneal fluid and blood. Adv Perit Dial. 2002;18:177–183.
- Shetty H, Gokal R. Treatment of infections in peritoneal dialysis. Contrib Nephrol. 2003;140:187–194.
- Diaz-Buxo JA. What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis? Contrib Nephrol. 2003;140:264–271.
- McLoughlin R. Resolving peritoneal inflammation: Flicking the right “switches”. Perit Dial Int. 2005;25:223–229.
- Henderson RB, Hobbs JA, Mathies M, Hogg N. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood. 2003;102:328–335.
- Tzamaloukas AH. What affects the outcome of peritoneal dialysis? Going beyond the microbial etiology. Perit Dial Int. 2002;22:563–565.
- Glik A, Douvdevani A. T lymphocytes: The “cellular” arm of acquired immunity in the peritoneum. Perit Dial Int. 2006;26:438–448.
- Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. The Ad Hoc Advisory Committee on Peritonitis Management. Perit Dial Int. 1989;9:247–256.
- Troidle L, Finkelstein F. Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob. 2006;5:6.
- Piraino B, Bailie GR, Bernardini J, ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107–131.
- Glik A, Mazar J, Rogachev B, Zlotnik M, Douvdevani A. CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment. Perit Dial Int. 2005;25:240–247.
- Zelenitsky S, Barns L, Findlay I, Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000;36:1009–1013.
- Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: An analysis of infecting pathogens. Am J Kidney Dis. 1995;26:47–53.
- Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1991;36:29–34.
- Krishnan M, Thodis E, Ikonomopoulos D, Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002;22:573–581.
- Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 2000;36:1000–1008.
- Bunke M, Brier ME, Golper TA. Culture-negative CAPD peritonitis: The Network 9 Study. Adv Perit Dial. 1994;10:174–178.
- Troidle L, Majahan A, Gorban-Breannan N, Kliger AS, Finkelstein FO. C-reactive protein, peritonitis and outcome. Perit Dial Int. 2001;21(Suppl. 1):S45.
- Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: A review and current concepts. Semin Dial. 2003;16:428–437.
- Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25:274–284.
- Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int. 2001;21:148–153.
- Szeto CC. Peritonitis-cells, cytokines, and local defense. Hong Kong J Nephrol. 2002;4:63–64.
- Martikainen TA, Ekstrand AV, Honkanen EO, Teppo AM, Gronhagen-Riska C. Dialysate leukocytes, sICAM-1, hyaluronan and IL-6: Predictors of outcome of peritonitis? Blood Purif. 2004;22:360–366.